Chen, G., Herr, M., Nowak, J., Ho, C., Almyroudis, N., Attwood, K., . . . Hahn, T. (2023). Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant. Haematologica (Roma), 108(2), 615-620. https://doi.org/10.3324/haematol.2022.281719
Chicago Style (17th ed.) CitationChen, George, et al. "Cytomegalovirus Reactivation After CD19 CAR T-cell Therapy Is Clinically Significant." Haematologica (Roma) 108, no. 2 (2023): 615-620. https://doi.org/10.3324/haematol.2022.281719.
MLA (9th ed.) CitationChen, George, et al. "Cytomegalovirus Reactivation After CD19 CAR T-cell Therapy Is Clinically Significant." Haematologica (Roma), vol. 108, no. 2, 2023, pp. 615-620, https://doi.org/10.3324/haematol.2022.281719.
Warning: These citations may not always be 100% accurate.